Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

A recent surge in misleading ads and AI-generated videos on social media and other online sites, promoting bogus diabetes ...

Weight-loss drugs offer initial benefits but often lead to weight regain after discontinuation. Bariatric surgery provides ...

Combining physician education with patient previsit activation increases deprescribing of diabetes medications, according to ...

A study may have found a cure for type 1 diabetes. Here, experts explain how the treatment, zimislecel, works and what it ...

A lower-sodium Dietary Approaches to Stop Hypertension-style diet was associated with clinically meaningful BP reduction in ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Among the four diet types trialed in this study, a modified version of the DASH diet with reduced sodium intake achieved a ...

A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

As Ohio cuts off state employees' coverage of medications for weight loss, a lawmaker who has benefited from the drugs wants to bring them back.

The group pointed to an initiative of Juha Sipilä's (Cen) government to increase users' co-payments for all diabetes ...